| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000026611 |
| Receipt No. | R000029883 |
| Scientific Title | Comparing the effectiveness of endoscopic duodenal stent placement and surgical gastrojejunostomy to treat gastric outlet obstruction in patients with advanced pancreatic cancer |
| Date of disclosure of the study information | 2017/03/21 |
| Last modified on | 2019/03/22 (Ver. 2) |
| Basic information | ||
| Public title | Comparing the effectiveness of endoscopic duodenal stent placement and surgical gastrojejunostomy to treat gastric outlet obstruction in patients with advanced pancreatic cancer
|
|
| Acronym | Comparing the effectiveness of endoscopic DS and surgical GJJ for GOO in patients with advanced pancreatic cancer
|
|
| Scientific Title | Comparing the effectiveness of endoscopic duodenal stent placement and surgical gastrojejunostomy to treat gastric outlet obstruction in patients with advanced pancreatic cancer
|
|
| Scientific Title:Acronym | Comparing the effectiveness of endoscopic DS and surgical GJJ for GOO in patients with advanced pancreatic cancer
|
|
| Region |
|
|
| Condition | |||||
| Condition | pancreatic cancer | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Malignancy | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To compare the efficacy and safety of surgical gastrojejunostomy(GJJ) and endoscopic duodenal stenting(DS) as palliative treatments for gastric outlet obstruction(GOO) in patients with advanced pancreatic cancer. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | To compare the survival duration after the procedure of GJJ with those of DS. |
| Key secondary outcomes | To compare the technical success rates, clinical success rates, adverse event, length of the hospital stay and chemotherapy start time of GJJ with those of DS. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Unresectable advanced pancreatic cancer
(2) Intestinal obstruction located from the distal one-third of the stomach to the distal duodenum (3) Gastric Outlet Obstruction Scoring System (GOOSS) score of 0 (no oral intake) or 1 (liquids only) |
|||
| Key exclusion criteria | We excluded those patients who had a structure in the proximal stomach or distal small intestine, another malignancy, a recurrent tumor, or a history of gastric or duodenal surgery, or had undergone previous gastrointestinal stent placement. | |||
| Target sample size | 70 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Gifu University Hospital | ||||||
| Division name | First Dept. of Internal Medicine | ||||||
| Zip code | 501-1194 | ||||||
| Address | 1-1 Yanagido, Gifu 501-1194 | ||||||
| TEL | 058-230-6308 | ||||||
| takuji@w7.dion.ne.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Gifu University Hospital | ||||||
| Division name | First Dept. of Internal Medicine | ||||||
| Zip code | 501-1194 | ||||||
| Address | 1-1 Yanagido, Gifu 501-1194 | ||||||
| TEL | 058-230-6308 | ||||||
| Homepage URL | |||||||
| ueshin550621@gmail.com | |||||||
| Sponsor | |
| Institute | First Dept. of Internal Medicine, Gifu University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | First Dept. of Internal Medicine, Gifu University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Gifu Prefectural General Medical Center
Gifu Municipal Hospital |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Gifu University Hospital Independent Ethics Committee |
| Address | 1-1 Yanagido, Gifu |
| Tel | 058-230-6059 |
| gjme00004@jim.gifu-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 岐阜大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | We retrospectively collected the data of consecutive patients who had undergone palliative treatment for GOO caused by pancreatic cancer at the Gifu University Hospital, Gifu Municipal Hospital, Gifu Prefectural General Medical Center between December 2008 and October 2015. we conducted this study to compare the efficacy and safety of GJJ with those of DS as types of palliative treatments for treating GOO in patients with advanced pancreatic cancer. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029883 |